Aspartyl-Cysteine

Metabolite details

Identifier

FKBFDTRILNZGAI-UHFFFAOYSA-N

InChI Key

FKBFDTRILNZGAI-UHFFFAOYSA-N

IUPAC name

3-amino-4-[(1-carboxy-2-sulanylethyl)amino]-4-oxobutanoic acid

Preferred name

Aspartyl-Cysteine

INN name

—

Synonym

—

ChEBI

CHEBI:174209

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD